A key role for transketolase-like 1 in tumor metabolic reprogramming

Oncotarget

Volumn 7, Issue 32, 2016, Pages 51875-51897

  Diaz Moralli, Santiago ^a   Aguilar, Esther ^a   Marin, Silvia ^a   Coy, Johannes F ^b,c   Dewerchin, Mieke ^d,e   Antoniewicz, Maciek R ^f   Meca Cortés, Oscar ^g   Notebaert, Leen ^d,e   Ghesquière, Bart ^d,e   Eelen, Guy ^d,e   Thomson, Timothy M ^g   Carmeliet, Peter ^d,e   Cascante, Marta ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Tavargenix GmbH   (Germany)

^c Rei stra e 1a   (Germany)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e Vesalius Research Center   (Belgium)

^f UNIVERSITY OF DELAWARE   (United States)

^g INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Lipid metabolism; Metabolic reprogramming; Pentose phosphate pathway; Transketolase like 1; Tumor metabolism

Indexed keywords

AMINO ACID; FATTY ACID; GLUCOSE; GLUTAMINE; LACTOSYLCERAMIDE; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TKTL1; SPHINGOLIPID; TRANSKETOLASE; UNCLASSIFIED DRUG; TKTL1 PROTEIN, HUMAN;

AMINO ACID METABOLISM; ANAEROBIC GLYCOLYSIS; ANGIOGENESIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; FATTY ACID SYNTHESIS; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIPID METABOLISM; METABOLIC REPROGRAMMING; NUCLEAR REPROGRAMMING; NUCLEIC ACID SYNTHESIS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TUMOR CELL; GLYCOLYSIS; METABOLISM; METABOLOME; NEOPLASM; TUMOR CELL LINE;

CELL LINE, TUMOR; GLYCOLYSIS; HUMANS; METABOLOME; NEOPLASMS; TRANSKETOLASE;

EID: 84982278647     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10429     Document Type: Article

References (58)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
2. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer cell. 2008; 13:472-482.
3. Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012; 491:364-373.
4. Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta. 2010; 1805:141-152.
5. Smith IM, Glazer CA, Mithani SK, Ochs MF, Sun W, Bhan S, Vostrov A, Abdullaev Z, Lobanenkov V, Gray A, Liu C, Chang SS, Ostrow KL, Westra WH, Begum S, Dhara M, et al. Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS One. 2009; 4:e4961.
6. Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014; 39:347-354.
7. Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, Zhao M, Rudek MA, Ha PK, Califano JA. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res. 2010; 16:857-866.
8. Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 2005; 51:257-273.
9. Coy JF, Dubel S, Kioschis P, Thomas K, Micklem G, Delius H, Poustka A. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics. 1996; 32:309-316.
10. Chen H, Yue JX, Yang SH, Ding H, Zhao RW, Zhang S. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J Exp Clin Cancer Res. 2009; 28:43.
11. Langbein S, Zerilli M, Zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP, Steidler A, Weiss C, Grobholz R, Willeke F, Alken P, Stassi G, Schubert P, Coy JF. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer. 2006; 94:578-585.
12. Volker HU, Hagemann C, Coy J, Wittig R, Sommer S, Stojic J, Haubitz I, Vince GH, Kammerer U, Monoranu CM. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. Am J Clin Pathol. 2008; 130:50-57.
13. Zerilli M, Amato MC, Martorana A, Cabibi D, Coy JF, Cappello F, Pompei G, Russo A, Giordano C, Rodolico V. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases. Cancer. 2008; 113:936-944.
14. Diaz-Moralli S, Tarrado-Castellarnau M, Alenda C, Castells A, Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PloS one. 2011; 6:e25323.
15. Kayser G, Sienel W, Kubitz B, Mattern D, Stickeler E, Passlick B, Werner M, Zur Hausen A. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology. 2011; 43:719-724.
16. Schwaab J, Horisberger K, Strobel P, Bohn B, Gencer D, Kahler G, Kienle P, Post S, Wenz F, Hofmann WK, Hofheinz RD, Erben P. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer. 2011; 11:363.
17. Xu X, Zur Hausen A, Coy JF, Lochelt M. Transketolaselike protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer. 2009; 124:1330-1337.
18. Hartmannsberger D, Mack B, Eggert C, Denzel S, Stepp H, Betz CS, Gires O. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro. Cancer Lett. 2011; 300:20-29.
19. Wanka C, Steinbach JP, Rieger J. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem. 2012; 287:33436-33446.
20. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, Swider CR, Sanchez PV, Lum JJ, Sayed N, Melo JV, Perl AE, Carroll M, Tuttle SW, Thompson CB. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene. 2010; 29:2962-2972.
21. Hu LH, Yang JH, Zhang DT, Zhang S, Wang L, Cai PC, Zheng JF, Huang JS. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs. 2007; 18:427-433.
22. Yuan W, Wu S, Guo J, Chen Z, Ge J, Yang P, Hu B, Chen Z. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo. Cancer Biol Ther. 2010; 9:710-716.
23. Horecker BL, Gibbs M, Klenow H, Smyrniotis PZ. The mechanism of pentose phosphate conversion to hexose monophosphate. I. With a liver enzyme preparation. J Biol Chem. 1954; 207:393-403.
24. Yevenes A, Frey PA. Cloning, expression, purification, cofactor requirements, and steady state kinetics of phosphoketolase-2 from Lactobacillus plantarum. Bioorg Chem. 2008; 36:121-127.
25. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, Thomas CJ, Vander Heiden MG, Cantley LC. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011; 334:1278-1283.
26. Hamanaka RB, Chandel NS. Cell biology. Warburg effect and redox balance. Science. 2011; 334:1219-1220.
27. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell metabolism. 2006; 3:177-185.
28. Miccheli A, Tomassini A, Puccetti C, Valerio M, Peluso G, Tuccillo F, Calvani M, Manetti C, Conti F. Metabolic profiling by 13C-NMR spectroscopy: [1, 2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie. 2006; 88:437-448.
29. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 2010; 9:3884-3886.
30. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2012; 481:380-384.
31. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2012; 481:385-388.
32. Zhang S, Yang JH, Guo CK, Cai PC. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer Lett. 2007; 253:108-114.
33. Feyen O, Coy JF, Prasad V, Schierl R, Saenger J, Baum RP. EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignancies. Future Oncol. 2012; 8:1349-1359.
34. Boros LG, Cascante M, Lee WN. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov Today. 2002; 7:364-372.
35. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011; 43:869-874.
36. Tong J, Xie G, He J, Li J, Pan F, Liang H. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. J Biomed Biotechnol. 2011; 2011:740564.
37. Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol. 2008; 10:1477-1483.
38. Bentz S, Pesch T, Wolfram L, de Valliere C, Leucht K, Fried M, Coy JF, Hausmann M, Rogler G. Lack of transketolaselike (TKTL) 1 aggravates murine experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2011; 300:G598-607.
39. Meshalkina LE, Drutsa VL, Koroleva ON, Solovjeva ON, Kochetov GA. Is transketolase-like protein, TKTL1, transketolase? Biochim Biophys Acta. 2013; 1832:387-390.
40. Schneider S, Ludtke S, Schroder-Tittmann K, Wechsler C, Meyer D, Tittmann K. A delta38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity. PLoS One. 2012; 7:e48321.
41. Schug ZT, Frezza C, Galbraith LC, Gottlieb E. The music of lipids: how lipid composition orchestrates cellular behaviour. Acta Oncol. 2012; 51:301-310.
42. Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu H, Khuri FR, Kang S, et al. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell. 2011; 44:864-877.
43. Lu CW, Lin SC, Chen KF, Lai YY, Tsai SJ. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem. 2008; 283:28106-28114.
44. Selivanov VA, Kovina MV, Kochevova NV, Meshalkina LE, Kochetov GA. Kinetic study of the H103A mutant yeast transketolase. FEBS Lett. 2004; 567:270-274.
45. Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, Walters H, Tantawy MN, Fu A, Manning HC, Horton JD, Hammer RE, McKnight SL, Tu BP. Acetate dependence of tumors. Cell. 2014; 159:1591-1602.
46. Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo SG, Kovacs Z, Foong C, Huang Z, Barnett S, Mickey BE, DeBerardinis RJ, Tu BP, Maher EA, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 2014; 159:1603-1614.
47. Gong N, Wei H, Chowdhury SH, Chatterjee S. Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. Proc Natl Acad Sci U S A. 2004; 101:6490-6495.
48. Kolmakova A, Rajesh M, Zang D, Pili R, Chatterjee S. VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo. Glycoconj J. 2009; 26:547-558.
49. Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009; 4:127-150.
50. Celia-Terrassa T, Meca-Cortes O, Mateo F, de Paz AM, Rubio N, Arnal-Estape A, Ell BJ, Bermudo R, Diaz A, Guerra-Rebollo M, Lozano JJ, Estaras C, Ulloa C, Alvarez-Simon D, Mila J, Vilella R, et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest. 2012; 122:1849-1868.
51. Obiol-Pardo C, Alcarraz-Vizan G, Cascante M, Rubio-Martinez J. Diphenyl urea derivatives as inhibitors of transketolase: a structure-based virtual screening. PLoS One. 2012; 7:e32276.
52. Gutmann I, Wahlefeld AW. (1974). L-(+)Lactate: Determination with lactate dehydrogenase and NAD. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. (New York: Academic Press), pp. 1464-1468.
53. Kunst A, Draeger B, Ziegenhorn J. (1984). D-Glucose. UV-methods with hexokinase and glucose 6-phosphate dehydrogenase. In: Bergmeyer HU, Bergmeyer J and Grassl M, eds. Methods of Enzymatic Analysis. (Weinheim: Verlag Chemie), pp. 163-172.
54. Alcarraz-Vizan G, Boren J, Lee WN, Cascante M. Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation. Metabolomics. 2010; 6:229-237.
55. Lee WN, Boros LG, Puigjaner J, Bassilian S, Lim S, Cascante M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1, 2-13C2]glucose. Am J Physiol. 1998; 274:E843-851.
56. Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM. Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Mol Cancer. 2009; 8:41.
57. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell metabolism. 2012; 15:110-121.
58. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statistics. 1979; 6:65-70.